267 related articles for article (PubMed ID: 32774057)
1. Non-invasive prediction of persistent villous atrophy in celiac disease.
Packova B; Kovalcikova P; Pavlovsky Z; Bartusek D; Prokesova J; Dolina J; Kroupa R
World J Gastroenterol; 2020 Jul; 26(26):3780-3791. PubMed ID: 32774057
[TBL] [Abstract][Full Text] [Related]
2. Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis.
Silvester JA; Kurada S; Szwajcer A; Kelly CP; Leffler DA; Duerksen DR
Gastroenterology; 2017 Sep; 153(3):689-701.e1. PubMed ID: 28545781
[TBL] [Abstract][Full Text] [Related]
3. Serum anti-tissue transglutaminase IgA and prediction of duodenal villous atrophy in adults with suspected coeliac disease without IgA deficiency (Bi.A.CeD): a multicentre, prospective cohort study.
Ciacci C; Bai JC; Holmes G; Al-Toma A; Biagi F; Carroccio A; Ciccocioppo R; Di Sabatino A; Gingold-Belfer R; Jinga M; Makharia G; Niveloni S; Norman GL; Rostami K; Sanders DS; Smecuol E; Villanacci V; Vivas S; Zingone F;
Lancet Gastroenterol Hepatol; 2023 Nov; 8(11):1005-1014. PubMed ID: 37696284
[TBL] [Abstract][Full Text] [Related]
4. The Role of an IgA/IgG-Deamidated Gliadin Peptide Point-of-Care Test in Predicting Persistent Villous Atrophy in Patients With Celiac Disease on a Gluten-Free Diet.
Lau MS; Mooney PD; White WL; Rees MA; Wong SH; Kurien M; Trott N; Leffler DA; Hadjivassiliou M; Sanders DS
Am J Gastroenterol; 2017 Dec; 112(12):1859-1867. PubMed ID: 29016564
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of serologic testing for celiac disease in ontario: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(21):1-111. PubMed ID: 23074399
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of a new point-of-care screening assay for celiac disease.
Benkebil F; Combescure C; Anghel SI; Besson Duvanel C; Schäppi MG
World J Gastroenterol; 2013 Aug; 19(31):5111-7. PubMed ID: 23964145
[TBL] [Abstract][Full Text] [Related]
7. AGA Clinical Practice Update on Diagnosis and Monitoring of Celiac Disease-Changing Utility of Serology and Histologic Measures: Expert Review.
Husby S; Murray JA; Katzka DA
Gastroenterology; 2019 Mar; 156(4):885-889. PubMed ID: 30578783
[TBL] [Abstract][Full Text] [Related]
8. Comparative usefulness of deamidated gliadin antibodies in the diagnosis of celiac disease.
Rashtak S; Ettore MW; Homburger HA; Murray JA
Clin Gastroenterol Hepatol; 2008 Apr; 6(4):426-32; quiz 370. PubMed ID: 18304884
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Yield of Isolated Deamidated Gliadin Peptide Antibody Elevation for Celiac Disease.
Hoerter NA; Shannahan SE; Suarez J; Lewis SK; Green PHR; Leffler DA; Lebwohl B
Dig Dis Sci; 2017 May; 62(5):1272-1276. PubMed ID: 28161854
[TBL] [Abstract][Full Text] [Related]
10. Use of deamidated gliadin peptide antibodies to monitor diet compliance in childhood celiac disease.
Monzani A; Rapa A; Fonio P; Tognato E; Panigati L; Oderda G
J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):55-60. PubMed ID: 21694536
[TBL] [Abstract][Full Text] [Related]
11. [Predictive value of serological tests in the diagnosis of celiac disease].
Carroccio A; Di Prima L; Falci C; Le Moli C; Soresi M; Montalto G; Notarbartolo A
Ann Ital Med Int; 2002; 17(2):102-7. PubMed ID: 12150043
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic utility of deamidated gliadin peptide antibody in celiac disease compared to anti-tissue transglutaminase and IgA- endomysium antibodies.
Sayed SK; Imam HM; Mahran AM; Refaiy AM
Egypt J Immunol; 2012; 19(2):41-52. PubMed ID: 23885406
[TBL] [Abstract][Full Text] [Related]
13. Resurrection of gliadin antibodies in coeliac disease. Deamidated gliadin peptide antibody test provides additional diagnostic benefit.
Kaukinen K; Collin P; Laurila K; Kaartinen T; Partanen J; Mäki M
Scand J Gastroenterol; 2007 Dec; 42(12):1428-33. PubMed ID: 17852878
[TBL] [Abstract][Full Text] [Related]
14. Tissue transglutaminase-serology markers for coeliac disease.
Kocna P; Vanícková Z; Perusicová J; Dvorák M
Clin Chem Lab Med; 2002 May; 40(5):485-92. PubMed ID: 12113293
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of mucosal status in the follow-up of pediatric patients with celiac disease: the role of serology.
Sengul OK; Akkelle BS; Ay P; Volkan B; Tutar E; Celikel CA; Ertem D
Eur J Pediatr; 2022 Sep; 181(9):3283-3289. PubMed ID: 35739293
[TBL] [Abstract][Full Text] [Related]
16. Antibodies against synthetic deamidated gliadin peptides as predictors of celiac disease: prospective assessment in an adult population with a high pretest probability of disease.
Niveloni S; Sugai E; Cabanne A; Vazquez H; Argonz J; Smecuol E; Moreno ML; Nachman F; Mazure R; Kogan Z; Gomez JC; Mauriño E; Bai JC
Clin Chem; 2007 Dec; 53(12):2186-92. PubMed ID: 17901114
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of anti-deamidated gliadin peptide IgG antibodies for celiac disease in children and IgA-deficient patients.
Mozo L; Gómez J; Escanlar E; Bousoño C; Gutiérrez C
J Pediatr Gastroenterol Nutr; 2012 Jul; 55(1):50-5. PubMed ID: 22197936
[TBL] [Abstract][Full Text] [Related]
18. Antibodies in the diagnosis of coeliac disease: a biopsy-controlled, international, multicentre study of 376 children with coeliac disease and 695 controls.
Wolf J; Hasenclever D; Petroff D; Richter T; Uhlig HH; Laaß MW; Hauer A; Stern M; Bossuyt X; de Laffolie J; Flemming G; Villalta D; Schlumberger W; Mothes T
PLoS One; 2014; 9(5):e97853. PubMed ID: 24830313
[TBL] [Abstract][Full Text] [Related]
19. Application of Deamidated Gliadin Antibodies in the Follow-Up of Treated Celiac Disease.
de Chaisemartin L; Meatchi T; Malamut G; Fernani-Oukil F; Hosking F; Rault D; Bellery F; Cellier C; Dragon-Durey MA
PLoS One; 2015; 10(8):e0136745. PubMed ID: 26322980
[TBL] [Abstract][Full Text] [Related]
20. Can celiac serology alone be used as a marker of duodenal mucosal recovery in children with celiac disease on a gluten-free diet?
Bannister EG; Cameron DJ; Ng J; Chow CW; Oliver MR; Alex G; Catto-Smith AG; Heine RG; Webb A; McGrath K; Simpson D; Hardikar W
Am J Gastroenterol; 2014 Sep; 109(9):1478-83. PubMed ID: 25070050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
